GlaxoSmithKline recalls the prescription heartburn medicine Zantac in all markets as a precaution days after the U.S. Food and Drug Administration finds 'unacceptable' levels of a probable cancer-causing impurity in the drug.
from CBC | Health News https://ift.tt/2p1vCLS
Aucun commentaire:
Enregistrer un commentaire